Private Trust Company’s Teva Pharmaceuticals TEVA Stock Holding History

Private Trust Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.91K	Hold	145	–	–	﹤0.01%	2289
2026 Q1	$4.37K	Hold	145	–	–	﹤0.01%	2228
2025 Q4	$4.53K	Sell	145 -7	-5%	-$172	﹤0.01%	2187
2025 Q3	$3.07K	Buy	+152	New	+$2.67K	﹤0.01%	2271
2024 Q3	–	Sell	-65	Closed	-$1.06K	–	2351
2024 Q2	$1.06K	Buy	+65	New	+$1K	﹤0.01%	2198
2023 Q1	–	Sell	-300	Closed	-$3K	–	2364
2022 Q4	$3K	Sell	300 -4,000	-93%	-$34.9K	﹤0.01%	1967
2022 Q3	$35K	Hold	4,300	–	–	0.01%	1020
2022 Q2	$32K	Buy	+4,300	New	+$37.5K	0.01%	1079
2016 Q1	–	Sell	-5,427	Closed	-$356K	–	323
2015 Q4	$356K	Buy	5,427 +1,876	+53%	+$116K	0.1%	220
2015 Q3	$200K	Sell	3,551 -828	-19%	-$53.7K	0.06%	302
2015 Q2	$258K	Buy	4,379 +401	+10%	+$24.7K	0.07%	269
2015 Q1	$247K	Sell	3,978 -344	-8%	-$20K	0.07%	281
2014 Q4	$248K	Buy	4,322 +186	+4%	+$10.4K	0.08%	252
2014 Q3	$222K	Buy	4,136 +9	+0.2%	+$477	0.08%	264
2014 Q2	$216K	Buy	4,127 +381	+10%	+$19.5K	0.07%	278
2014 Q1	$198K	Sell	3,746 -168	-4%	-$7.76K	0.07%	251
2013 Q4	$157K	Buy	3,914 +247	+7%	+$9.73K	0.06%	250
2013 Q3	$139K	Buy	3,667 +309	+9%	+$12.1K	0.06%	254
2013 Q2	$132K	Buy	+3,358	New	+$131K	0.06%	245

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Private Trust Company's TEVA Position: Q2 2026 in Review

Private Trust Company held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 145 shares worth $4.91K. The position accounts for ﹤0.01% of the portfolio, ranked #2289.

Private Trust Company first reported a position in TEVA in Q2 2013 and has held it in 19 quarters since. The position peaked at $356K in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Private Trust Company held 145 shares of Teva Pharmaceuticals worth $4.91K as of Q2 2026.
Private Trust Company left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2289 holding.
Private Trust Company first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 19 quarters since.
Private Trust Company's Teva Pharmaceuticals position peaked at $356K in Q4 2015.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.